pancreatic cancer phenotype

Aliases

pancreatic

Related entities (1)

Mentioned in (75)

Papers in which this entity is mentioned.

• Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
• Chromosomal instability as a driver of cancer progression. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
• Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
• Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. (2023)
• Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. (2023)
• Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. (2023)
• Deterministic evolution and stringent selection during preneoplasia. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction. (2021)
• Nanopore sequencing technology, bioinformatics and applications. (2021)
• Application of third-generation sequencing in cancer research. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
• Inferring structural variant cancer cell fraction. (2020)
• Pan-cancer landscape of homologous recombination deficiency. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Accucopy: Accurate and Fast Inference of Allele-specific Copy Number Alterations from Low-coverage Low-purity Tumor Sequencing Data (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
• Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
• The Immune Landscape of Cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
• One-Carbon Metabolism in Health and Disease. (2017)
• Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
• Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
• Benchmark Dose Modeling Estimates of the Concentrations of Inorganic Arsenic That Induce Changes to the Neonatal Transcriptome, Proteome, and Epigenome in a Pregnancy Cohort. (2017)
• Dysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder. (2017)
• Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
• An open access pilot freely sharing cancer genomic data from participants in Texas. (2016)
• Fragment Length of Circulating Tumor DNA. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• Prognostic value of inflammation-based scores in patients with osteosarcoma. (2016)
• Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. (2016)
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
• Clock-like mutational processes in human somatic cells. (2015)
• Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
• The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
• PyClone: statistical inference of clonal population structure in cancer. (2014)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Cancer genome landscapes. (2013)
• Visualizing genomic information across chromosomes with PhenoGram. (2013)
• Signatures of mutational processes in human cancer. (2013)
• A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. (2013)
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
• Managing incidental findings and research results in genomic research involving biobanks and archived data sets. (2012)
• Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• Massive genomic rearrangement acquired in a single catastrophic event during cancer development. (2011)
• BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
• Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. (2011)
• Automated medical image segmentation techniques. (2010)
• Integrative analysis of the melanoma transcriptome. (2010)
• Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. (2010)
• Cellular metabolic stress: considering how cells respond to nutrient excess. (2010)
• Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. (2006)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.